FTC pulls re­main­ing case against Ab­b­Vie; New EU clin­i­cal tri­als sys­tem com­ing in 2022; Abing­worth bets big on CymaBay

The Fed­er­al Trade Com­mis­sion on Fri­day with­drew its re­main­ing case against Ab­b­Vie af­ter the Supreme Court de­clined to re­view a low­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.